<DOC>
	<DOCNO>NCT00186706</DOCNO>
	<brief_summary>Does oral selenium supplement increase blood level antioxidants patient establish , smoking-related lung disease ? Members study group recently discover elevated level anti-oxidant GPx-1 may protective heart disease . We study whether selenium supplementation improve GPx-1 level .</brief_summary>
	<brief_title>Selenium Supplementation Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description>Patients chronic obstructive pulmonary disease ( COPD ) high risk atherosclerotic heart disease , part nearly universal exposure heavy smoking , part incompletely understood mechanism may include inflammation anti-oxidant status . Smoking markedly affect circulate inflammatory marker concentration , anti-oxidant glutathione peroxidase-1 ( GPx-1 ) . We hypothesize smoking-related inflammation anti-oxidant consumption lead cardiovascular ( CV ) respiratory disease . In recent study , ( Blankenberg et al ) find high level GPx-1 associate low rate af future CV event death . GPx-1 level low among smoker , combination current smoke GPx-1 level median strongly ( HR=5.6 ) significantly associate future CV event death . There biological epidemiological rationale study selenium supplementation CV protection . GPx-1 selenium-dependent enzyme , data support hypothesis selenium supplementation increase GPx activity various disease . Furthermore , epidemiologic study discover inverse association selenium content soil CV incidence mortality . We hypothesize selenium supplementation elevate intra-erythrocytic GPx-1 level COPD patient , ultimately , retard CV progression . In study , test first component assertion . In randomized , placebo-controlled trial , determine whether 12 week selenium supplementation increase GPx-1 level among 120 COPD patient . If successful , study may lead future large clinical trial ass whether selenium , inexpensive safe mineral , improve clinical outcome cardiovascular respiratory disease .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>1 . Aged 40 year old ( upper limit ) . 2 . Established Respirologistdiagnosed mild moderate COPD , accord Canadian Thoracic Society ( CTS ) Lung Function Guidelines . ( 33 ) For diagnosis mild COPD , patient must FEV1 60 % 79 % predict FEV1 / FVC &lt; 0.7 . For diagnosis moderate COPD , patient must FEV1 40 % 59 % predict FEV1 / FVC &lt; 0.7 . 3 . Current former smoker &gt; 20 packyear smoke history . 4 . Ability provide inform consent . 5 . Women subject must postmenopausal . 1 . Current recent ( within 4 week ) acute exacerbation chronic bronchitis 2 . Current daily use mineral vitamin + mineral supplement natural health product provide daily dose selenium great 100 Âµg 3 . Current daily use &gt; 5000 U vitamin A , &gt; 1000 mg vitamin C , &gt; 800 U vitamin E 4 . Known significant comorbidity renal ( creatinine &gt; 150 mol/L ) hepatic disease ( AST ALT &gt; 3 time normal ) . Measurement requirement study . Creatinine Alanine aminotransferase ( ALT ) measure begin end study . 5 . Known suspect active cancer nonmelanoma skin cancer . 6 . Other concurrent major respiratory diagnosis COPD/asthma . 7 . Plan start statin drug 12 week study drug ( may enroll statin start &gt; 1 month current study enrollment defer study completion ) . 8 . Consumption brazil nut . 9 . Individuals homocystinuria 10 . On niacin daily dose 500 mg high hyperlipidemia . 11 . If allergy product contain dicalcium phosphate , talc sugarloaf , steric acid , silica .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Selenium</keyword>
	<keyword>Chronic Obstructive Pulmonaary Disease</keyword>
	<keyword>Cardiovascular Disease</keyword>
	<keyword>Anti-oxidant</keyword>
	<keyword>Pulmonary</keyword>
</DOC>